- Exchange: Korea SE
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Dongsung Pharmaceutical Co Ltd
+ Add to Watchlist002210:KS
5,580 KRW 20 0.36%As of 02:17:59 ET on 05/24/2013.
Snapshot for Dongsung Pharmaceutical Co Ltd (002210)
| Open: | 5,620 | Day's Range: | 5,500 - 5,640 | Volume: | 306,580 |
|---|---|---|---|---|---|
| Previous Close: | 5,560 | 52wk Range: | 2,335 - 6,800 | 1-Yr Rtn: | +139.31% |
Key Statistics for 002210
| Current P/E Ratio (ttm) | 58.1250 |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. KOSPI | 2.2350 |
| Earnings Per Share (ttm) | 96.0000 |
| Est. EPS (12/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M KRW) | 121,456.84 |
| Shares Outstanding (M) | 21.77 |
| 30 Day Average Volume | 1,465,854 |
| Price/Book (mrq) | 1.6367 |
| Price/Sale (ttm) | 1.2561 |
| Dividend Indicated Gross Yield | 0.54% |
| Cash Dividend (KRW) | 30.0000 |
| Last Dividend | 12/27/2012 |
| 5 Year Dividend Growth | 0.00% |
| Next Earnings Announcement | 02/28/2014 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 002210
No data available
Company Profile & Key Executives for 002210
Dongsung Pharmaceutical Co., Ltd. manufactures pharmaceutical products, such as antibiotics and dermatological medicines. The Company also produces and markets cosmetic products.
| Kim Yeon-SuVice Chairman | Lee Yang-GuVP/Rep Director |
| Gweon Jung-MuVice President | Kim In-GyuSenior Managing Director |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
002210 News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page